Daniel Lightwood
Head of Antibody Discovery and Optimisation, Ucb @UCB
Signup · Get unlimited contacts
WORK HISTORY
Head of Antibody Discovery and Optimisation, Ucb @UCB
GB
Leading the Antibody Discovery and Optimisation Department at UCB Pharma - heading up a team of scientists using B cell and display technologies, as well as several digital tools to discover and optimise monoclonal antibody therapeutics.
EDUCATION
University of Cambridge
Doctor of Philosophy - PhD, Biochemistry and Molecular Biology
ABOUT DANIEL LIGHTWOOD
After receiving a first class BSc Hons degree at Reading University, UK (1996), I undertook a PhD at the University of Cambridge, Biochemistry Department in the area of protein engineering (graduated I then joined Celltech (acquired by UCB in 2004) in During my time at UCB, I have played a key role in leading and developing UCB’s world-leading antibody discovery platform and have been responsible for successfully applying the technology across a number of UCB therapeutic antibody programs. I currently hold the position of Head of Antibody Discovery and Optimisation at UCB managing a team of around 30 scientists covering both immune-based and in vitro display-based approaches for discovering and engineering the highest quality monoclonal antibodies.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.